Alert: The Plaza Building will remain closed through Jan. 20, 2025.

Learn More

university research bulletin graphic

May 4, 2021 Research Bulletin

Volume 2, Issue 9
NewsEvents

Featured Funding Opportunities

NIH Funding Announcements

NIH funding opportunities and notices are presented weekly. Please see the current and past updates below.

Limited Funding Opportunities

Currently we are seeing an increase in the number of limited institutional grant opportunities in which we can nominate a single applicant from our institution. Due to the short turn-around time we will have a modified and shortened process for these types of grant opportunities.

For the limited institutional grant opportunities below, please submit a brief summary (one page or less) and biosketch by the date indicated.

W.M. Keck Foundation

Focus includes:

  • Basic Science early in the process.
  • Cutting-Edge Research. Your project must be novel, distinct, and pioneering; it must push the edge of the field, present unconventional approaches, and challenge the prevailing paradigm. The Keck Foundation often finds it appealing if traditional sources of funding find the project too risky and are unwilling to support it.
  • Impact. If successful, your project must have the potential for transformative change.
  • Instrumentation. They like the development of promising new technology. Investigators at all career stages are acceptable.
  • Cross-disciplinary team science is encouraged

The W.M. Keck Foundation does NOT provide support for clinical trials or for disease-specific research.

Deadlines:

  • Concept Deadline – May 25, 2021. The University’s Review Committee will select up to 4 one-page concepts that will be submitted to the Keck Foundation.
  • Concepts will be reviewed with the Foundation in July 2021 for pre-counseling advice.
  • Phase 1 Application Deadline – November 1, 2021, if chosen by campus to submit.
  • Full Proposal Deadline – February 15, 2021, if invited by the Keck Foundation.

Single-page concepts should include the following in 12 point font with 1 inch margins:

  1. Overview of the proposed project emphasizing any unique aspects and pilot studies; indicate area of emphasis for project (i.e. medical research or science and engineering research)
  2. Description of the methodologies and key personnel
  3. Brief justification of the need for Keck support and how Federal agencies will not fund the research (provide comments from federal agencies turning down the research)
  4. Estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies, etc. (budgets can be rough approximations at this stage). The Foundation will not fund indirect costs and they only allow up to 10% of the PI’s annual salary.

Please review information on the W.M Keck Foundation website on research funded in the past.

National Center for Chronic Disease Prevention and Health Promotion within the Centers for Disease Control and Prevention

CDC-RFA-DP21-2112

National Center for Chronic Disease Prevention and Health Promotion within the Centers for Disease Control and Prevention is seeking applications for the opportunity titled “Expanding the National Approach to Chronic Disease Education and Awareness”

Institutions are limited to one application (see page 10 of the RFA). The applicant must propose a single chronic disease to focus on during the life of the grant. The proposed chronic disease cannot currently be funded in CDC’s FY21 Congressional budget; it cannot have a dedicated funding line in the FY 2021 Appropriations Act.

  • Materials due to Internal Review Committee: May 14, 2021
  • Sponsor Due Date: June 21, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by May 14, 2021.

NIH Director’s Early Independence Award

DP5 - Clinical Trial Optional in the High-Risk, High-Reward Research program

The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.

Applications are welcome that propose any research topic relevant to the broad mission of NIH and from any eligible institution. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.

  • Materials due to Internal Review Committee: June 8, 2021
  • Sponsor Due Date: September 3, 2021

Enables outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete her/his doctoral degree or clinical training and have the support and guarantee of an independent research position from a host institution.

  • Single-PI applications only
  • Complete doctoral degree or clinical training between June 1, 2020 and September 30, 2022
  • In non-independent research position at time of application
  • Cannot have served in a postdoctoral position for more than 12 months before June 1, 2020
  • Requires significant institutional commitment
  • Limited to two applications per institution

Additional details can be located at Early Independence Award website and RFA RM-21-018.

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by June 8, 2021.

Social Security Administration

ICAP-ICAP-21-001

The Social Security Administration (SSA) is offering a funding opportunity titled “Interventional Cooperative Agreement Program (ICAP-ICAP-21-001). The purpose of this program is to employ interventional research to target the increased employment and self-sufficiency of individuals with disabilities who currently receive or will apply for Disability Insurance (DI) or Supplemental Security Income (SSI) Programs. Note that a 40% cost share is required.

  • Materials due to Internal Review Committee: May 14, 2021
  • Sponsor Due Date: June 21, 2021

Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format to limited.submissions@cuanschutz.edu by May 14, 2021.

Just Released

Fiscal Year 2021 (FY21) pre-announcements and funding opportunities for the Department of Defense (DoD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP) are below.

FY21 Program Announcements Released:

Breast Cancer Research Program (BCRP)

  • Breakthrough Award Levels 1 and 2
  • Breakthrough Award Level 3
  • Breakthrough Award Level 4
  • Era of Hope Scholar Award
  • Innovator Award
  • Transformative Breast Cancer Consortium Award

Bone Marrow Failure Research Program (BMFRP)

  • Idea Development Award
  • Investigator-Initiated Research Award

Kidney Cancer Research Program (KCRP)

  • Concept Award
  • Idea Development Award
  • Postdoctoral and Clinical Fellowship Award
  • Translational Research Partnership Award

Lupus Research Program (LRP)

  • Idea Award
  • Impact Award
  • Transformative Vision Award

FY21 Pre-Announcement Released:

Duchenne Muscular Dystrophy (DMDRP)

  • Idea Development Award
  • Translational Research Award

Special Announcements

Novel Therapeutics for Genetic Disease

CU Innovations is partnering with BridgeBio to develop new treatments for diseases with an underlying genetic basis. We are seeking researchers who have therapeutic technology they would like to advance toward clinical development. BridgeBio has initiated a call for proposals in the following areas of interest:

  • Genetic diseases – e.g., Mendelian diseases, repeat expansion diseases, and cancers with germline or somatic driver mutations.
  • Proof of principle demonstrating a therapeutic can directly modulate the underlying genetic target – e.g., directly inhibits a gain-of-function protein, addresses a loss-of-function, or directly compensates for the activity of a defective protein.

View the selection criteria.

Applications are due Monday, May 12, 2021.

For additional information and questions, contact cuinnovations@cuanschutz.edu.

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.   

Past Research Bulletins can be found here.

Please click here if you wish to be added to this distribution.

Office of the Vice Chancellor for Research

CU Anschutz

Fitzsimons Building

13001 East 17th Place

WG109

Mail stop F520

Aurora, CO 80045

Leadership
Resources
CMS Login